Indication

Bacteremia Due to Staphylococcus Aureus

1 clinical trial

1 product

Clinical trial

Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy for the Treatment of Adults With Bacteremia Due to Staphylococcus Aureus

Status: Recruiting, Estimated PCD: 2024-12-01

Product